Abstract
To evaluate the different traits of mesenchymal stem cell (MSC) isolated from osteosarcoma (OS) and normal bone marrow (BM) induced by bone-morphogenetic protein-2 (BMP-2). MSCs from implanted osteosarcoma or femur bone marrow were isolated and cultured. Differentiation potency was verified and phenotypes were evaluated by flow cytometry. Increased or decreased expressions of BMP-2 were delivered by adenovirus and lentivirus vector, respectively. Expressions of VEGF, EMMPRIN, and MMP-9 were examined. Cell cycle, apoptosis, invasiveness, and proliferation assays were performed between the transfected groups and controls. Increased BMP-2 induced over-expression of VEGF, EMMPRIN, and MMP-9 in OS- and BM-MSCs both intra- and extra-cellularly. Decreased BMP-2 expression induced inhibition of the factors. Increased BMP-2 also induced less population of cells at G1 phase, more apoptotic cells, more cells that invade through Transwell membrane, and faster proliferation in OSMSC compared to those in BMMSC. BMP-2 induced higher expression of tumorigenic factors, which could be responsible for promoting the proliferation and aggressiveness of OSMSC over BMMSC.
Similar content being viewed by others
References
Alborzinia H, Schmidt-Glenewinkel H, Ilkavets I, Breitkopf-Heinlein K, Cheng X, Hortschansky P, Dooley S, Wölfl S. Quantitative kinetic analysis of BMP2 uptake into cells and its modulation by BMP-antagonists. J Cell Sci. 2012. doi:10.1242/jcs.109777.
Amado L. C.; Saliaris A. P.; Schuleri K. H.; St John M.; Xie J. S.; Cattaneo S.; Durand D. J.; Fitton T.; Kuang J. Q.; Stewart G.; Lehrke S.; Baumgartner W. W.; Martin B. J.; Heldman A. W.; Hare J. M. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A. 102: 11474–11479; 2005.
Bergers G.; Brekken R.; McMahon G.; Vu T. H.; Itoh T.; Tamaki K.; Tanzawa K.; Thorpe P.; Itohara S.; Werb Z.; Hanahan D. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol. 2: 737–744; 2000.
Cheng H.; Fukushima T.; Takahashi N.; Tanaka H.; Kataoka H. Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases. Cancer Res 69: 1828–1835; 2009.
Digirolamo C. M.; Stokes D.; Colter D.; Phinney D. G.; Class R.; Prockop D. J. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol. 107: 275–281; 1999.
Dvorak H. F.; Brown L. F.; Detmar M.; Dvorak A. M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 146: 1029–1039; 1995.
Ghosh-Choudhury N.; Ghosh-Choudhury G.; Celeste A.; Ghosh P. M.; Moyer M.; Abboud S. L.; Kreisberg J. Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cells. Biochim Biophys Acta. 1497: 186–196; 2000.
Gouze J. N.; Stoddart M. J.; Gouze E.; Palmer G. D.; Ghivizzani S. C.; Grodzinsky A. J.; Evans C. H. In vitro gene transfer to chondrocytes and synovial fibroblasts by adenoviral vectors. Methods Mol Med. 100: 147–164; 2004.
Guo H.; Majmudar G.; Jensen T. C.; Biswas C.; Toole B. P.; Gordon M. K. Characterization of the gene for human EMMPRIN, a tumor cell surface inducer of matrix metalloproteinases. Gene. 220: 99–108; 1998.
Han J.; Yong B.; Luo C.; Tan P.; Peng T.; Shen J. High serum alkaline phosphatase cooperating with MMP-9 predicts metastasis and poor prognosis in patients with primary osteosarcoma in Southern China. World J Surg Oncol. 10: 37; 2012. doi:10.1186/1477-7819-10-37.
Hardy S.; Kitamura M.; Harris-Stansil T.; Dai Y.; Phipps M. L. Construction of adenovirus vectors through Cre-lox recombination. J Virol. 71: 1842–1849; 1997.
Hatakeyama S.; Gao Y. H.; Ohara-Nemoto Y.; Kataoka H.; Satoh M. Expression of bone morphogenetic proteins of human neoplastic epithelial cells. Biochem Mol Biol Int. 42: 497–505; 1997.
Hicklin D. J.; Ellis L. M. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 23: 1011–1027; 2005. Review.
Igarashi M.; Yogiashi Y.; Mihara M.; Takada I.; Kitagawa H.; Kato S. Vitamin K induces osteoblast differentiation through pregnane X receptor-mediated transcriptional control of the Msx2 gene. Mol Cell Biol. 27: 7947–7954; 2007.
Ji J. F.; He B. P.; Dheen S. T.; Tay S. S. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells. 22: 415–427; 2004.
Kaya M.; Wada T.; Kawaguchi S.; Nagoya S.; Yamashita T.; Abe Y.; Hiraga H.; Isu K.; Shindoh M.; Higashino F.; Okada F.; Tada M.; Yamawaki S.; Ishii S. Increased pre-therapeutic serum vascular endothelial growth factor in patients with early clinical relapse of osteosarcoma. Br J Cancer. 86: 864–869; 2002a.
Kaya M.; Wada T.; Kawaguchi S.; Nagoya S.; Yamashita T.; Abe Y.; Hiraga H.; Isu K.; Shindoh M.; Higashino F.; Okada F.; Tada M.; Yamawaki S.; Ishii S. Increased pre-therapeutic serum vascular endothelial growth factor in patients with early clinical relapse of osteosarcoma. Br J Cancer. 86: 864–869; 2002b.
Koç O. N.; Lazarus H. M. Mesenchymal stem cells: heading into the clinic. Bone Marrow Transplant 27: 235–239; 2001. Review.
Li Y.; Xu J.; Chen L.; Zhong W. D.; Zhang Z.; Mi L.; Zhang Y.; Liao C. G.; Bian H. J.; Jiang J. L.; Yang X. M.; Li X. Y.; Fan C. M.; Zhu P.; Fu L.; Chen Z. N. HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection. Histopathology 54: 677–687; 2009.
Liotta L. A. Tumor invasion and metastases—role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res 46: 1–7; 1986. Review.
Liu Z.; Li Y.; Yang R. Effects of resveratrol on vascular endothelial growth factor expression in osteosarcoma cells and cell proliferation. Oncol Lett. 4(4): 837–839; 2012.
Massague J.; Chen Y. G. Controlling TGF-beta signaling. Genes Dev. 14: 627–644; 2000.
Meirelles Lda S.; Nardi N. B. Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br J Haematol. 123: 702–711; 2003.
Muramatsu T.; Miyauchi T. Basigin (CD147): a multifunctional transmembrane protein involved in reproduction, neural function, inflammation and tumor invasion. Histol Histopathol 18: 981–987; 2003. Review.
Nishimura R.; Kato Y.; Chen D.; Harris S. E.; Mundy G. R.; Yoneda T. Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12. J Biol Chem. 273: 1872–1879; 1998.
Nohe A.; Hassel S.; Ehrlich M.; Neubauer F.; Sebald W.; Henis Y. I.; Knaus P. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J Biol Chem. 277: 5330–5338; 2002.
Peister A.; Mellad J. A.; Larson B. L.; Hall B. M.; Gibson L. F.; Prockop D. J. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood. 103: 1662–1668; 2004.
Picci P.; Mercuri M.; Ferrari S.; Alberghini M.; Briccoli A.; Ferrari C.; Pignotti E.; Bacci G. Survival in high-grade osteosarcoma: improvement over 21 years at a single institution. Ann Oncol. 21: 1366–1373; 2010.
Phinney D. G.; Kopen G.; Isaacson R. L.; Prockop D. J. Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation. J Cell Biochem. 72: 570–585; 1999.
Rastogi S.; Kumar R.; Sankineani S. R.; Marimuthu K.; Rijal L.; Prakash S.; Jalan D.; Khan S. A.; Sharma M. C. Role of vascular endothelial growth factor as a tumour marker in osteosarcoma: a prospective study. Int Orthop. 36(11): 2315–21; 2012.
Rodriguez-Manzaneque J. C.; Lane T. F.; Ortega M. A.; Hynes R. O.; Lawler J.; Iruela-Arispe M. L. Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor. Proc Natl Acad Sci U S A. 98: 12485–12490; 2001.
Satake K.; Lou J.; Lenke L. G. Migration of mesenchymal stem cells through cerebrospinal fluid into injured spinal cord tissue. Spine (Phila Pa 1976) 29: 1971–1979; 2004.
Studeny M.; Marini F. C.; Dembinski J. L.; Zompetta C.; Cabreira-Hansen M.; Bekele B. N.; Champlin R. E.; Andreeff M. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst. 96: 1593–1603; 2004.
Takahashi Y.; Tucker S. L.; Kitadai Y.; Koura A. N.; Bucana C. D.; Cleary K. R.; Ellis L. M. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg. 132: 541–546; 1997.
Tuschl T.; Zamore P. D.; Lehmann R.; Bartel D. P.; Sharp P. A. Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev. 13: 3191–7; 1999.
Vogel G. Embryonic stem cells. Stem cells not so stealthy after all. Science. 297: 175–177; 2002.
Wynn R. F.; Hart C. A.; Corradi-Perini C.; O'Neill L.; Evans C. A.; Wraith J. E.; Fairbairn L. J.; Bellantuono I. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood. 104: 2643–2645; 2004.
Yan L.; Zucker S.; Toole B. P. Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression. Thromb Haemost 93: 199–204; 2005.
Zhang G.; Li M.; Jin J.; Bai Y.; Yang C. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9. Asian Pac J Cancer Prev. 12(8): 2075–80; 2011.
Zhou Q.; Zhu Y.; Deng Z.; Long H.; Zhang S.; Chen X. VEGF and EMMPRIN expression correlates with survival of patients with osteosarcoma. Surg Oncol 20: 13–19; 2011. Review.
Acknowledgments
The authors report no conflict of interest. This study was supported in part by the Wuxi Health Bureau, no. YGZX1106.
Author information
Authors and Affiliations
Corresponding author
Additional information
Editor: T. Okamoto
Rights and permissions
About this article
Cite this article
Yang, X., Wang, Yp., Liu, Fx. et al. Increased invasiveness of osteosarcoma mesenchymal stem cells induced by bone-morphogenetic protein-2. In Vitro Cell.Dev.Biol.-Animal 49, 270–278 (2013). https://doi.org/10.1007/s11626-013-9598-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11626-013-9598-0